# OnCo record paper-kim-anticancer-pricing-reimbursement-korea-erpor-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-kim-anticancer-pricing-reimbursement-korea-erpor-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-kim-anticancer-pricing-reimbursement-korea-erpor-2021" ;
  schema:name "Trends in the pricing and reimbursement of new anticancer drugs in South Korea"@en ;
  schema:description "Thirty-two new cancer drugs reviewed in Korea between 2017 and 2020 took on average 36.7 months to reach the insurance list, and the drugs listed at lower prices relative to other countries were listed faster."@en ;
  schema:url <https://onco.cc/key-papers/paper-kim-anticancer-pricing-reimbursement-korea-erpor-2021/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1080/14737167.2021.1860023>, <https://pubmed.ncbi.nlm.nih.gov/33275463/> ;
  schema:sameAs <https://doi.org/10.1080/14737167.2021.1860023> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Kim S, Kim J, Cho H, Lee K, Ryu C, Lee JH" ;
  onco:institutions <https://onco.cc/institutions/hira/> .